TGF‐β and EGF can synergistically promote malignant phenotypes, such as epithelial‐to‐mesenchymal transition, which is a crucial process in cancer invasion and metastasis (Richter et al., 2011; Uttamsingh et al., 2008; Xu et al., 2010). Here, EGF is linked to cancer.